N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
about
Oxidative stress and cerebral endothelial cells: regulation of the blood-brain-barrier and antioxidant based interventionsEvaluation of a dithiocarbamate derivative as a model of thiol oxidative stress in H9c2 rat cardiomyocytes.Pro-oxidant and antioxidant effects of N-acetylcysteine regulate doxorubicin-induced NF-kappa B activity in leukemic cellsPummelo protects Doxorubicin-induced cardiac cell death by reducing oxidative stress, modifying glutathione transferase expression, and preventing cellular senescenceAn authentic imaging probe to track cell fate from beginning to end.Evaluation of Oxidative DNA Damage Using an Alkaline Single Cell Gel Electrophoresis (SCGE) Comet Assay, and the Protective Effects of N-Acetylcysteine Amide on Zearalenone-induced Cytotoxicity in Chang Liver Cells.Ginsenoside Rb1 Inhibits Doxorubicin-Triggered H9C2 Cell Apoptosis via Aryl Hydrocarbon Receptor.Mechanisms and management of doxorubicin cardiotoxicity.Doxorubicin-Mediated Cardiotoxicity: Role of Mitochondrial Connexin 43.Comparative evaluation of N-acetylcysteine and N-acetylcysteineamide in acetaminophen-induced hepatotoxicity in human hepatoma HepaRG cells.Responses to reductive stress in the cardiovascular system.Caffeic acid phenylethyl ester and MG132, two novel nonconventional chemotherapeutic agents, induce apoptosis of human leukemic cells by disrupting mitochondrial function.Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo.Impact of N-acetylcysteine on neonatal cardiomyocyte ischemia-reperfusion injury.Role of hypoxia-inducible factors in the dexrazoxane-mediated protection of cardiomyocytes from doxorubicin-induced toxicity.The antitumor effects of tetrodotoxin and/or doxorubicin on Ehrlich ascites carcinoma-bearing female mice.
P2860
Q26851676-C6469757-0FD1-4030-8C20-947BD13ADE5AQ33572622-CEFC0839-6D86-4715-A45E-67C08F62C826Q35915757-F6081617-22FC-4358-B8BE-891E4589CC3EQ36587599-6618D1ED-7541-4BE7-90EF-D72078F53254Q36855902-8F5DB956-E9D6-4D46-B990-D3313593E01AQ37326486-B2C7688C-224B-45BB-B2FD-C6719658E0C9Q37685108-A7F09665-15DB-4782-BECB-45621431EC0DQ38473474-94040C10-1A74-4B9E-8B52-925879C1EA85Q38924111-9411C031-D02E-44DE-8143-C1CA19A213DFQ38954228-CA60D9CD-3D0F-44AF-B373-9022D6FB5359Q39035367-57597D5E-FA97-4A85-831C-A8EEE188CDF4Q39190612-EA47A057-BC66-4148-B47F-67B84B5858E6Q39249531-52240DC5-F14F-4EFF-A872-AA24F2FBBBB3Q39572164-238B3283-E7AF-4A63-9E9A-27A1B5827876Q39608341-B4694F59-85E2-4C29-8500-6113FCA1AB08Q46719842-63DE2493-3E34-4AC2-ABEB-C313BF84ED0C
P2860
N-acetylcysteine amide decreases oxidative stress but not cell death induced by doxorubicin in H9c2 cardiomyocytes.
description
2009 nî lūn-bûn
@nan
2009 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@ast
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@en
type
label
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@ast
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@en
prefLabel
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@ast
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@en
P2093
P2860
P356
P1433
P1476
N-acetylcysteine amide decreas ...... ubicin in H9c2 cardiomyocytes.
@en
P2093
Chuan-Chin Huang
Robert S Aronstam
Yue-Wern Huang
P2860
P2888
P356
10.1186/1471-2210-9-7
P577
2009-04-15T00:00:00Z
P5875
P6179
1002899099